Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.00
Bid: 47.00
Ask: 49.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.255%)
Open: 48.00
High: 48.00
Low: 48.00
Prev. Close: 48.00
MIG3 Live PriceLast checked at -
Maven Income and Growth VCT 3 is an Investment Trust

To achieve long-term capital appreciation and generate income for Shareholders by investing in a diversified portfolio of securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

6 Apr 2022 13:45

RNS Number : 5101H
Maven Income and Growth VCT 3 PLC
06 April 2022
 

 

Maven Income and Growth VCT 3 PLC (the Company)

Result of Annual General Meeting

 

At the Annual General Meeting of the Company held at 1-2 Royal Exchange Buildings, London EC3V 3LF on Wednesday 6 April 2022 at 12.30 pm, all of the Resolutions put to the Meeting were passed.

 

At the record date for the Annual General Meeting, being 4 April 2022, the total number of voting rights in the Company stood at and the total shares in issue were 96,818,862. The Company advises that for the Annual General Meeting, valid proxy appointments were made in respect of 5,863,341 shares and that the number of proxy votes lodged for each Resolution were as follows:

 

Resolutions

For

Discretion

Against

Withheld

Total

1

To receive the Directors' Report and audited Financial Statements

5,587,410

253,561

4,956

17,414

5,863,341

2

To approve the Directors' Remuneration Report

4,895,280

301,780

616,094

50,187

5,863,341

3

To approve a final dividend payment

5,605,577

251,662

6,102

0

5,863,341

4

To re-elect Atul Devani as a Director

5,462,785

253,561

75,435

71,560

5,863,341

5

To re-elect David Allan as a Director

5,479,977

253,561

20,562

109,241

5,863,341

6

To re-elect Bill Nixon as a Director

5,200,640

253,561

76,127

333,013

5,863,341

7

To re-elect Keith Pickering as a Director

5,271,989

253,561

270,772

67,019

5,863,341

8

To re-appoint Deloitte LLP as Auditor

4,667,398

310,268

817,388

68,287

5,863,341

9

To authorise the Directors to fix the remuneration of the Auditor

5,239,763

400,163

182,997

40,418

5,863,341

10

To authorise the Directors to allot new shares

5,014,051

242,697

556,346

50,247

5,863,341

11

To authorise disapplication of pre-emption rights

4,736,240

265,172

764,512

97,417

5,863,341

12

To authorise the Company to purchase its own shares

4,857,471

240,482

729,511

35,877

5,863,341

13

To allow a General Meeting to be called on not less than 14 days' notice

5,368,572

240,482

235,692

18,595

5,863,341

 

A vote withheld is not a vote in law and any such votes have not been included in the votes for or against the respective Resolutions. The voting figures will be available to view at: www.mavencp.com/migvct3.

 

A copy of the Resolutions passed at the 2022 AGM have been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://www.fca.org.uk/markets/primary-markets/regulatory-disclosures/national-storage-mechanism.

 

 

Issued on behalf of the Board

Maven Capital Partners UK LLP, Secretary

6 April 2022

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGBKABQBBKDBQK
Date   Source Headline
7th Sep 20213:08 pmRNSStatement re Dividend Investment Scheme
16th Aug 20214:08 pmRNSTransaction in Own Shares
13th Aug 20212:13 pmRNSHalf-year Report
5th Aug 20214:39 pmRNSTransaction in Own Shares
3rd Aug 202111:31 amRNSStatement re NAV and Interim Dividend
16th Jun 20213:16 pmRNSStatement re Offer for Subscription
16th Apr 202110:25 amRNSIssue of Equity
15th Apr 20214:30 pmRNSTransaction in Own Shares
13th Apr 20212:22 pmRNSStatement re Dividend Investment Scheme
12th Apr 20219:00 amRNSNet Asset Value(s)
7th Apr 202112:28 pmRNSResult of AGM
5th Mar 20214:39 pmRNSFinal Results
29th Jan 20212:55 pmRNSTransaction in Own Shares
22nd Jan 20213:17 pmRNSNAV and Proposed Final Dividend
17th Nov 20204:29 pmRNSTransaction in Own Shares
16th Nov 20204:55 pmRNSTransaction in Own Shares
11th Nov 20204:58 pmRNSNet Asset Value(s)
28th Aug 202010:28 amRNSIssue of Equity
26th Aug 20205:23 pmRNSTransaction in Own Shares
21st Aug 20204:10 pmRNSStatement re NAV and DIS
29th Jul 20204:45 pmRNSTransaction in Own Shares
28th Jul 20204:44 pmRNSTransaction in Own Shares
24th Jul 20203:23 pmRNSHalf-year Report
9th Jul 202010:00 amRNSIssue of Equity
29th Jun 20205:25 pmRNSStatement re NAV and Interim Dividend
8th Jun 20209:33 amRNSAllotment Update
15th May 20204:55 pmRNSTransaction in Own Shares
7th May 20204:35 pmRNSPublication of Suppl.Prospcts
8th Apr 20203:56 pmRNSStatement re Offer for Subscription
8th Apr 202012:38 pmRNSResult of AGM
26th Mar 20205:25 pmRNSUpdate on Net Asset Value
26th Mar 20205:00 pmRNSAllotment Update & Suspension of DIS
19th Mar 20204:30 pmRNSAGM Update – Notification of Change of Venue
10th Mar 20204:41 pmRNSAnnual Financial Report
19th Feb 20204:09 pmRNSTransaction in Own Shares
5th Feb 202010:36 amRNSDirector/PDMR Shareholding
5th Feb 202010:32 amRNSIssue of Equity
28th Jan 202011:40 amRNSStatement re Offer for Subscription
20th Jan 20205:12 pmRNSTransaction in Own Shares
17th Jan 20204:45 pmRNSTransaction in Own Shares
17th Jan 202012:22 pmRNSNet Asset Value and Proposed Final Dividend
10th Dec 201912:28 pmRNSResult of General Meeting
4th Dec 20199:45 amRNSStatement re Share Premium Account Cancellation
20th Nov 20194:26 pmRNSTransaction in Own Shares
14th Nov 20196:20 pmRNSStatement re Offer for Subscription
24th Oct 20194:06 pmRNSTransaction in Own Shares
23rd Oct 20194:43 pmRNSNet Asset Value(s)
2nd Sep 20193:34 pmRNSDirector/PDMR Shareholding
2nd Sep 20193:26 pmRNSIssue of Equity
30th Aug 20194:27 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.